BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17868034)

  • 1. The covalent modification and regulation of TLR8 in HEK-293 cells stimulated with imidazoquinoline agonists.
    Rajagopal R; Waller AS; Mendoza JD; Wightman PD
    Biochem J; 2008 Jan; 409(1):275-87. PubMed ID: 17868034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostimulatory activity of Toll-like receptor 8 agonists towards human leucocytes: basic mechanisms and translational opportunities.
    Philbin VJ; Levy O
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1485-91. PubMed ID: 18031250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation.
    Larangé A; Antonios D; Pallardy M; Kerdine-Römer S
    J Leukoc Biol; 2009 Apr; 85(4):673-83. PubMed ID: 19164127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA recognition via TLR7 and TLR8.
    Hornung V; Barchet W; Schlee M; Hartmann G
    Handb Exp Pharmacol; 2008; (183):71-86. PubMed ID: 18071655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
    Jurk M; Kritzler A; Schulte B; Tluk S; Schetter C; Krieg AM; Vollmer J
    Eur J Immunol; 2006 Jul; 36(7):1815-26. PubMed ID: 16783850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.
    Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS
    J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ovine TLR7 and TLR8 protein coding regions, detection of mutations and Maedi Visna virus infection.
    Mikula I; Bhide M; Pastorekova S; Mikula I
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):51-9. PubMed ID: 20638136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides.
    Gorden KK; Qiu XX; Binsfeld CC; Vasilakos JP; Alkan SS
    J Immunol; 2006 Nov; 177(10):6584-7. PubMed ID: 17082568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.
    Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I
    J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of bovine Toll-like receptor 8: ligand specificity, signaling essential sites and dimerization.
    Zhu J; Brownlie R; Liu Q; Babiuk LA; Potter A; Mutwiri GK
    Mol Immunol; 2009 Feb; 46(5):978-90. PubMed ID: 18995910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of the toll-like receptor 8 gene in the Chinese raccoon dog (Nyctereutes procyonoides).
    Yang Y; Tong M; Yi L; Cheng Y; Zhang M; Cao Z; Wang J; Lin P; Cheng S
    Immunol Lett; 2016 Oct; 178():50-60. PubMed ID: 27481482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective and direct activation of human neutrophils but not eosinophils by Toll-like receptor 8.
    Janke M; Poth J; Wimmenauer V; Giese T; Coch C; Barchet W; Schlee M; Hartmann G
    J Allergy Clin Immunol; 2009 May; 123(5):1026-33. PubMed ID: 19361845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural reorganization of the Toll-like receptor 8 dimer induced by agonistic ligands.
    Tanji H; Ohto U; Shibata T; Miyake K; Shimizu T
    Science; 2013 Mar; 339(6126):1426-9. PubMed ID: 23520111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phosphorylation site in the Toll-like receptor 5 TIR domain is required for inflammatory signalling in response to flagellin.
    Ivison SM; Khan MA; Graham NR; Bernales CQ; Kaleem A; Tirling CO; Cherkasov A; Steiner TS
    Biochem Biophys Res Commun; 2007 Jan; 352(4):936-41. PubMed ID: 17157808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Toll-like receptor 7/8-ligand resiquimod (R-848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet-activating factor biosynthesis.
    Hattermann K; Picard S; Borgeat M; Leclerc P; Pouliot M; Borgeat P
    FASEB J; 2007 May; 21(7):1575-85. PubMed ID: 17264163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.
    Cherfils-Vicini J; Platonova S; Gillard M; Laurans L; Validire P; Caliandro R; Magdeleinat P; Mami-Chouaib F; Dieu-Nosjean MC; Fridman WH; Damotte D; Sautès-Fridman C; Cremer I
    J Clin Invest; 2010 Apr; 120(4):1285-97. PubMed ID: 20237413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.
    Hurst J; Prinz N; Lorenz M; Bauer S; Chapman J; Lackner KJ; von Landenberg P
    Immunobiology; 2009; 214(8):683-91. PubMed ID: 19249118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal regulatory protein alpha negatively regulates both TLR3 and cytoplasmic pathways in type I interferon induction.
    Dong LW; Kong XN; Yan HX; Yu LX; Chen L; Yang W; Liu Q; Huang DD; Wu MC; Wang HY
    Mol Immunol; 2008 Jun; 45(11):3025-35. PubMed ID: 18471880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A functional toll-like receptor 8 variant is associated with HIV disease restriction.
    Oh DY; Taube S; Hamouda O; Kücherer C; Poggensee G; Jessen H; Eckert JK; Neumann K; Storek A; Pouliot M; Borgeat P; Oh N; Schreier E; Pruss A; Hattermann K; Schumann RR
    J Infect Dis; 2008 Sep; 198(5):701-9. PubMed ID: 18605904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
    Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
    J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.